240 related articles for article (PubMed ID: 2031322)
21. [The possibility of performing an incisional biopsy in skin melanomas during pulsed laser radiation treatment].
Vagner RI; Kozlov AP; Moskalik KG
Vopr Onkol; 1990; 36(7):859-62. PubMed ID: 2399669
[TBL] [Abstract][Full Text] [Related]
22. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of prognostic characteristics of stage I cutaneous malignant melanoma.
Tan GJ; Baak JP
Anal Quant Cytol; 1984 Sep; 6(3):147-54. PubMed ID: 6508033
[TBL] [Abstract][Full Text] [Related]
24. [Survival analysis in patients with cutaneous malignant melanoma].
Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
[TBL] [Abstract][Full Text] [Related]
25. [Prognosis of malignant melanoma following dissection regional lymph node metastases].
Sprakel B; Stenschke F; Unnewehr M; Ladas A; Senninger N
Chirurg; 2003 Jan; 74(1):55-60. PubMed ID: 12552406
[TBL] [Abstract][Full Text] [Related]
26. Malignant melanoma.
Califano J; Nance M
Facial Plast Surg Clin North Am; 2009 Aug; 17(3):337-48. PubMed ID: 19698915
[TBL] [Abstract][Full Text] [Related]
27. [Stage I malignant melanoma of the skin. Prognostic value of thickness and level (author's transl)].
Palangié A; Lassau F; Moreau T; Noury-Duperrat G; Cottenot F
Nouv Presse Med; 1981 Jun; 10(28):2337-41. PubMed ID: 7267338
[TBL] [Abstract][Full Text] [Related]
28. Prognostic models in melanoma.
Halpern AC; Schuchter LM
Semin Oncol; 1997 Feb; 24(1 Suppl 4):S2-7. PubMed ID: 9122730
[TBL] [Abstract][Full Text] [Related]
29. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
30. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
[TBL] [Abstract][Full Text] [Related]
31. Pathologic and clinical features influencing outcome of thin cutaneous melanoma: correlation with newly proposed staging system.
Finley JW; Gibbs JF; Rodriguez LM; Letourneau R; Driscoll D; Kraybill W
Am Surg; 2000 Jun; 66(6):527-31; discussion 531-2. PubMed ID: 10888127
[TBL] [Abstract][Full Text] [Related]
32. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.
Statius Muller MG; van Leeuwen PA; de Lange-De Klerk ES; van Diest PJ; Pijpers R; Ferwerda CC; Vuylsteke RJ; Meijer S
Cancer; 2001 Jun; 91(12):2401-8. PubMed ID: 11413531
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the prognostic significance of the site of origin of cutaneous melanoma.
Law MM; Wong JH
Am Surg; 1994 May; 60(5):362-6. PubMed ID: 8161088
[TBL] [Abstract][Full Text] [Related]
34. [Prognostic histopathological features of cutaneous malignant melanomas. New statistical approach (author's transl)].
Le Doussal V; Brunet M; Guérin P; Hacène K; Lasry S; Marcotorchino F; Michaud P; Hébert H
Ann Pathol; 1981; 1(2):130-9. PubMed ID: 7284057
[TBL] [Abstract][Full Text] [Related]
35. [Surgical treatment of malignant melanoma of the skin with special reference to the vertical tumor diameter].
Waclawiczek HW; Umlauft M; Weitgasser R
Chirurg; 1984 Aug; 55(8):508-11. PubMed ID: 6488996
[TBL] [Abstract][Full Text] [Related]
36. A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma.
Balch CM; Soong SJ; Murad TM; Ingalls AL; Maddox WA
Surgery; 1979 Aug; 86(2):343-51. PubMed ID: 462379
[TBL] [Abstract][Full Text] [Related]
37. [Malignant melanoma in life insurance--thickness or anatomic layer?].
Müller WA; Erlanger M
Versicherungsmedizin; 1994 Dec; 46(6):193-5. PubMed ID: 7825264
[TBL] [Abstract][Full Text] [Related]
38. Morphological analysis of malignant melanoma cases with prolonged survival.
Gábor Z; Sugár J; Gulbert A; Venkei T
Neoplasma; 1977; 24(4):431-6. PubMed ID: 904747
[TBL] [Abstract][Full Text] [Related]
39. 2010 TNM staging system for cutaneous melanoma...and beyond.
Gershenwald JE; Soong SJ; Balch CM;
Ann Surg Oncol; 2010 Jun; 17(6):1475-7. PubMed ID: 20300965
[No Abstract] [Full Text] [Related]
40. [Clinical aspects and prognosis of malignant melanoma].
Heite HJ
Haematol Blood Transfus; 1978; 21():233-47. PubMed ID: 738636
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
